Generally, cholinergic drugs can be used for degenerative brain diseases, such as AD, by inhibiting acetylcholinesterase (AChE) or modulating muscarinic acetylcholine receptors (mAChRs) and nicotinic acetylcholine receptors [5]. This evidence concerns the gene ACHE and Alzheimer disease.